Literature DB >> 28193095

Intraocular Ependymoma With Blood-Filled Spaces: Neoplasm or a Reactive Process With Ependymal Differentiation-A Dilemma.

Aditi Dewan1, Ravindra Kumar Saran1, Smriti Nagpal Gupta2, Deepanjali Arya2, Ruchi Goel2.   

Abstract

Intraocular glial lesions are rare and include retinal gliosis, hamartomas, and astrocytomas and rarely ependymomas. Ependymomas are slow-growing glial tumors preferentially arising in the central nervous system (CNS), occasionally presenting at sites outside the CNS, with only 2 cases of primary retinal ependymoma reported till date. We report herein the third such case of a 20-year-old male who presented with a painful blind eye. The enucleated specimen showed presence of a glial tumor with cells arranged in sheets as well as few true rosettes and pseudo-rosettes and an immunohistochemical profile similar to a classical ependymoma at usual sites in the CNS. Additionally, the presence of blood-filled spaces and few proliferating blood vessels made it a diagnostic challenge. All retinal glial lesions are positive for GFAP and S100. Therefore, immunostaining for EMA as well as the MIB-1-labeling index maybe vital in differentiating ependymomas from other intraocular glial lesions.

Entities:  

Keywords:  EMA; glial; gliosis; intraocular ependymoma; vasoproliferative tumor of retina

Mesh:

Substances:

Year:  2017        PMID: 28193095     DOI: 10.1177/1066896917692098

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

Review 1.  Optic Pathway-Hypothalamic Glioma Apoplexy: A Report of Two Cases and Systematic Review of the Literature.

Authors:  Saleh Baeesa; Yazid Maghrabi; Rana Moshref; Jaudah Al-Maghrabi
Journal:  Front Surg       Date:  2022-05-30

2.  Massive Retinal Gliosis in Microphthalmic Globe With Cyst Masquerading as a Neoplasm.

Authors:  Ruchi Goel; Shweta Raghav; Ayushi Agarwal; Ravindra Saran; Akash Raut
Journal:  Cureus       Date:  2021-06-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.